Integragen Appoints Gerard Vaillant as Non-Executive Director
Complete the form below to unlock access to ALL audio articles.
IntegraGen has announced the appointment of Gerard Vaillant as non-executive Director.
Gerard Vaillant brings 35 years of experience in commercial diagnostic companies, most notably as Company Group Chairman of Johnson & Johnson and Chairman of Ortho Clinical Diagnostics.
Welcoming Gerard Vaillant as a new board member, Dr.Jan Mous, President and CEO said, "I am very proud to announce the appointment of such a prominent person to the board of Directors of IntegraGen."
"Gerard brings both the experience and the strategic vision to support us at a turning point in the life of our company, when we move into the commercialization phase of our prognostic genetic tests, IntegraTests™"
During his career, Gerard Vaillant has held numerous prestigious positions in the healthcare sector including Group Chairman of Johnson & Johnson (J&J), Chairman of Ortho-Clinical Diagnostics, Inc. and Therakos, Inc., Worldwide President of Lifescan, VP of J&J, and Managing Director of Ortho-Diagnostics Systems in France.
He also sits in the boards of Sensor For Medicine and Science, Inc (US), Luminex (US) and Tecan (CH).
Commenting on his appointment at IntegraGen, Gerard Vaillant added, "Since its creation 5 years ago, IntegraGen has reached significant development milestones in its focus areas of Diabetes, Obesity and Autism and has recently opened its first Expert Centre, in Bonn, Germany for MODY (Maturity Onset Diabetes of the Young) diabetes testing."
"I am delighted to join the company at such an exciting time to help them build a world leading position in the predictive medicine business."
